معرفی
Sally Johnson is a researcher with 821 citations and significant contributions to understanding the long-term effects of COVID-19, particularly focusing on dyspnea, lung function, sleep disorders, and mental health impacts. Her work centers on the PHOSP-COVID study, a major UK research initiative examining post-hospitalization outcomes from SARS-CoV-2 infection.
Her research spans immunology, respiratory medicine, and mental health, with particular expertise in post-acute sequelae of viral infections. Johnson has made notable contributions to understanding the relationship between sleep disturbances and respiratory symptoms following hospitalization for COVID-19, as well as immune aging patterns in severe disease cases.
Johnson's 2021 publication in The Lancet Respiratory Medicine on physical, cognitive, and mental health impacts after hospitalization for COVID-19 has been highly influential with 445 citations, establishing foundational knowledge about long-COVID manifestations. Her more recent 2024 work on accelerated immune aging provides critical insights into immunological mechanisms of disease severity.
She has also contributed to research on domestic and sexual violence against patients with severe mental illness (2015), which has garnered 167 citations, demonstrating her broader interest in mental health issues beyond the pandemic context.
Johnson has led two significant research projects: the Science Education Enhancement Project (2004-2007) funded by the Science Enhancement Programme, and Science Teaching Training in Western Cape, South Africa (1999-2003) funded by the Nuffield Foundation. Her work has been widely disseminated through numerous news outlets, academic platforms, and social media channels, reflecting its substantial impact on both scientific and public understanding of post-COVID conditions.